Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback